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Abstract Waddlia chondrophila is considered as an emerg-
ing human pathogen likely involved in miscarriage and
lower respiratory tract infections. Given the low sensitivity
of cell culture to recover such an obligate intracellular
bacteria, molecular-based diagnostic approaches are war-
ranted. We thus developed a real-time PCR that amplifies
Waddlia chondrophila DNA. Specific primers and probe
were selected to target the 16S rRNA gene. The PCR
specifically amplified W. chondrophila but did not amplify
other related-bacteria such as Parachlamydia acanthamoebae,
Simkania negevensis and Chlamydia pneumoniae. The PCR
exhibited a good intra-run and inter-run reproducibility and a
sensitivity of less than ten copies of the positive control. This
real-time PCR was then applied to 32 nasopharyngeal
aspirates taken from children with bronchiolitis not due to
respiratory syncytial virus (RSV). Three samples revealed to
be Waddlia positive, suggesting a possible role of this
Chlamydia-related bacteria in this setting.
Introduction
During the last 15 years, several Chlamydia-related bacteria
have been discovered [1–3]. Among them, Simkania
negevensis and Parachlamydia acanthamoebae seem to
be implicated in bronchiolitis in children and pneumonia
in adults [4, 5]. Waddlia chondrophila was isolated twice
from aborted bovine fetuses [6, 7] and a seroepidemio-
logical study revealed a strong association between W.
chondrophila seropositivity and miscarriage in humans
[8]. In addition, DNA of W. chondrophila was amplified
from the sputum of a patient suffering from pneumonia
[9]. Moreover, W. chondrophila showed rapid replication
in human macrophages [10]. Detection of this obligate
intracellular bacterium is limited by its inability to grow
on axenic media. We thus developed a real-time
diagnostic PCR assay to specifically detect W. chondro-
phila DNA and applied it to samples from patients with
bronchiolitis.
Material and methods
Using Primer3 software [11], a forward primer WadF4 (5′-
GGCCCTTGGGTCGTAAAGTTCT-3′), a reverse primer
WadR4 (5′CGGAGTTAGCCGGTGCTTCT-3′) and a probe
WadS2 (5′-FAM-CATGGGAACAAGAGAAGGATG-
BHQ-3′) were selected to amplify a 101-bp fragment of
the 16S rRNA gene of both W. chondrophila strains
available to date: strain ATCC VR-1470 (LGC Promochem,
Molsheim, France) and strain 2032/99 (K. Sachse, Jena,
Germany). The probe contained locked nucleic acids
(underlined in sequence above).
Both strains were grown in Acanthamoeba castellanii
ATCC 30010 and purified on sucrose and gastrographin, as
previously described [12]. Bacterial DNA was then
extracted using QIAamp DNA Mini kit (Qiagen, Hilden,
Germany). A 16S rRNA gene plasmid positive control was
constructed using primers WadF3 (5′-CAGTCGA
GAATCTTTCGCAAT-3′) and WadR4, as described [13].
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PCR reactions were performed with 0.2 μM of each
primer, 0.1 μM of probe and iTaq supermix with ROX
(BioRad, Reinach, Switzerland). Cycling conditions were
2 min at 50°C, 3 min at 95°C followed by 45 cycles of
15 s at 95°C and 1 min at 60°C. Amplification and
detection of PCR products were performed with ABI
Prism 7000 (Applied Biosystems, Foster City, USA). To
assess the analytical specificity of this new real-time
PCR, we tested DNA extracted from 20 different
bacterial strains (Table 1). We also tested DNA of A.
castellanii ATCC 30010 and human DNA (Roche Diag-
nostics, Mannheim, Germany). A PCR inhibition control
(4 μl DNA spiked with 1 μl positive control) was used for
all these DNA to verify that absence of amplification was
due to the specificity of the PCR and not to the presence
of PCR inhibitors. To assess the analytical sensitivity, 10-
fold serial dilutions (105 to 100 copies) of the positive
plasmid control were tested in duplicates in 15 different
runs.
Intra-run reproducibility was assessed on 75 duplicates
by plotting the Ct (threshold cycle) values of both
duplicates against each other on a graph, by plotting the
differences between both duplicates against the mean of
each duplicate and by calculating the 95% confidence
interval using the Bland-Altman algorithm (GraphPad 5.0).
To assess the inter-run reproducibility, the mean Ct of
duplicates obtained in 15 independent runs were compared
for each concentration of plasmid DNA.
Results and discussion
Genomic DNA of the two Waddlia strains available in co-
culture were successfully amplified by this 16S rRNA gene
real-time PCR with Ct values of 19 when samples with
approximately 105 DNA copies/μl were tested. The
analytical sensitivity of the real-time PCR was of about
ten copies of plasmid control DNA. Indeed, when testing
ten-fold dilutions of plasmid, nine of 15 replicates were
positive at a concentration of one copy whereas all 15
replicates were positive at a concentration of ten copies.
Although the assay is essentially based on the specificity of
the probe, analytical specificity was high. No cross-
amplification was observed when testing microorganisms
listed in Table 1, which indicates that the specificity of the
probe ensured a high degree of discrimination between the
amplicons of Waddlia chondrophila and those of the other
tested bacteria. Intra-run reproducibility was high as shown
Bacterial species Source/strain
Bacteroides fragilis ATCC25825
Chlamydia suis S45/6 a
Chlamydia abortus S26/3 b
Chlamydia pecorum W73 a
Chlamydia psittaci T49/90 c
Chlamydia pneumoniae K6 d
Criblamydia sequanensis CRIB-18
Escherichia coli ATCC 25922
Haemophilus influenzae ATCC 49247
Legionella pneumophila Clinical specimen e
Moraxella catharralis Clinical specimen e
Neochlamydia hartmannellae ATCC 50802
Parachlamydia acanthamoebae strain BN9 ATCC VR-1476
Parachlamydia acanthamoebae strain Hall’s coccus ATCC VR-1476
Protochlamydia amoebophila strain UWE25 ATCC PRA-7
Pseudomonas aeruginosa ATCC 27853
Rhabdochlamydia crassificans CRIB-01
Simkania negevensis ATCC VR-1471
Staphylococcus aureus ATCC 25923
Streptococcus mitis ATCC 6249
Table 1 Bacterial species used
to test the specificity of the
Waddlia real-time PCR
a Kindly provided by J. Storz,
Baton Rouge Louisiana, LA,
USA
b Kindly provided by G.E.
Jones, Moredun Research Insti-
tute, Edinburgh, UK
c Kindly provided by R.K.
Hoop, Zürich, Switzerland
d Kindly provided by A.
Pospischil, Zürich, Switzerland
e Kindly provided by Christian
Durussel, Lausanne, Switzerland
Fig. 1 a Plot of cycle threshold (Ct) values of first duplicate versus
second duplicate showing intra-run reproducibility. The solid line
represents the linear regression whereas the dashed lines represent the
95% prediction interval. b Bland-Altman graph representing the Ct
difference between both duplicates according to the average Ct of
duplicates. The dashed line represents the 95% confidence interval (CI
95%). c Inter-run and intra-run reproducibilities assessed using 101 to
105 positive control plasmid copies in 15 successive runs. Error bars
represent the standard error of the mean of duplicates (intra-run
reproducibility)
b
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in Fig. 1, with Ct of both duplicates being relatively similar
with a correlation coefficient r2 of 0.976 (Fig. 1a). In
Fig. 1b, the Bland-Altman graph revealed that the 95%
confidence interval was 1.72 cycles. Inter-run reproducibil-
ity is shown in Fig. 1c. The standard deviation values
reflect small deviation from the mean and indicate good
reproducibility among different runs. Thus, the quantifica-
tion was highly reliable from 101 to 105 copies, with an
average difference of 3 cycles per ten-fold dilution (Fig.1c).
The sensitivity of this W. chondrophila real-time PCR,
which was less than ten copies, is excellent and comparable
to other diagnostic TaqMan PCR assays [14, 15]. This real-
time PCR is more sensitive than the 16SigF-Rp2Chlam
broad range PCR [16], which only detects about 1,000
copies of DNA [14]. Thus, this real-time PCR allows
detection of Waddlia DNA not detectable by classical PCR.
This increased sensitivity is likely a result of the real-time
technology, which combines amplification of small length
amplicons and detection with an highly sensitive fluores-
cent probe.
As the role of W. chondrophila in lower respiratory tract
infections is possible [9], we applied our real-time PCR to
32 nasopharyngeal aspirates from children with bronchio-
litis not due to respiratory syncytial virus (RSV), which is
the most common etiology of bronchiolitis. Waddlia DNA
was detected in three samples. The characteristics of these
three patients are summarized in Table 2. Briefly, these
three female patients all exhibited symptoms of bronchio-
litis. Another microbial etiology was identified in one of the
three patients.
In conclusion, we developed a new W. chondrophila real-
time PCR. The assay revealed to be specific with a very low
detection limit and its application to clinical samples allowed
detection of W. chondrophila DNA in three samples taken
from children with bronchiolitis. However, more patients
should be investigated in order to confirm a possible role of
W. chondrophila in bronchiolitis. In the future, our Waddlia
diagnostic PCR could be useful to define the role of Waddlia
in other human diseases, such as pneumonia and miscarriage.
Since the format of this real-time PCR assay is compatible
with 384-well plates, the test will also be useful for screening
large numbers of samples to investigate the public health risk
of this amoeba-resisting bacterium.
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